Health ❯ Healthcare ❯ Women's Health

Hormone Replacement Therapy

Menopause Breast Cancer Risk FDA Regulations Risks and Benefits Care Quality Commission Patient-Provider Communication Forms of HRT Cognitive Decline Type 2 Diabetes and HRT Black Box Warnings Alzheimer's Disease Risk Contraceptive Pills Risks of HRT Estrogen Patches Estrogen-based Products

Hims & Hers Expands Access to Lilly Weight-Loss Drugs as Shares Jump 7%

The shift signals a move from compounded copies to a subscription platform built around branded GLP‑1 therapies.

FDA Removes Broad Boxed Warnings From Many Menopause Hormone Therapies

FDA Begins Expert Review of Menopause Hormone Therapy Warnings

Meta-Analysis Reveals Opposing Breast Cancer Risks of Hormone Replacement Therapy in Women Under 55